C12Y 204/01027
Dna beta-glucosyltransferase
Official title: DNA beta-glucosyltransferase (2.4.1.27)
C12Y204/01027 (Dna beta-glucosyltransferase) appears on 9 US grants and 16 published applications in this corpus.
Search patents in C12Y- Granted patents
- 9
- Published applications
- 16
- Assignees
- 9
- Inventors
- 31
- Latest grant
- 27 Aug 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 2 |
| 2018 | 1 | 2 |
| 2019 | 1 | 1 |
| 2020 | 2 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 3 |
| 2023 | 1 | 1 |
| 2024 | 3 | 0 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Bisulfite-free, base-resolution identification of cytosine modifications27 Aug 2024US 12,071,660 B2Ludwig Institute for Cancer Research
- Bisulfite-free, base-resolution identification of cytosine modifications21 May 2024US 11,987,843 B2Ludwig Institute for Cancer Research
- Bisulfite-free, base-resolution identification of cytosine modifications16 Apr 2024US 11,959,136 B2Ludwig Institute for Cancer Research
- Enzymatic production of alpha-1,3-glucan27 Jun 2023US 11,685,907 B2Nutrition & Biosciences USA 4, Inc.
- Bisulfite-free, base-resolution identification of cytosine modifications19 Apr 2022US 11,306,355 B2Ludwig Institute for Cancer Research
- Methods for analysis of dna methylation23 Jul 2026US 2026/0209842 A1Guardant Health, Inc.
- Methods of using cpg binding proteins in mapping modified cytosine nucleotides25 Dec 2025US 2025/0388894 A1Illumina, Inc.
- Bisulfite-free, base-resolution identification of cytosine modifications9 Jan 2025US 2025/0011861 A1Ludwig Institute for Cancer Research
- Double-Stranded DNA Deaminases and Uses Thereof9 Nov 2023US 2023/0357838 A1New England Biolabs, Inc.
- Detecting methylcytosine and its derivatives using s-adenosyl-l-methionine analogs (xsams)15 Sep 2022US 2022/0290234 A1Illumina Cambridge Limited
Most cited
By later US patents